临床上,经常有部分患者可出现HBV再激活,即:HBsAg阳性/抗-HBc阳性,或HBsAg阴性/抗-HBc阳性患者接受免疫抑制剂治疗或化疗时,HBV DNA较基线升高2 lg IU/mL,或基线HBV DNA阴性者转为阳性,或HBsAg由阴性转为阳性。
参考文献:1. Gane, E.J, et al. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. J Viral Hepat, 2020. 27: p. 466-475.